Literature DB >> 7359122

REM ocular activity in Parkinsonian patients chronically treated with levodopa.

P Lavie, E Bental, H Goshen, B Sharf.   

Abstract

REM ocular activity of levodopa treated Parkinsonian patients was compared to REM ocular activity of normal young adults. REM densities were significantly higher in patients than in normal controls. This difference was most prominent after 10 min of REM sleep. Previous findings that levodopa treated patients reported usually vivid and detailed dreams suggest that increase in REM ocular activity is underlying the new dreaming experiences.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7359122     DOI: 10.1007/bf01256640

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

1.  The relation of eye movements, body motility, and external stimuli to dream content.

Authors:  W DEMENT; E A WOLPERT
Journal:  J Exp Psychol       Date:  1958-06

2.  Eye movements and visually active dreams.

Authors:  H Firth; I Oswald
Journal:  Psychophysiology       Date:  1975-09       Impact factor: 4.016

3.  Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride.

Authors:  C Guilleminault; D Raynal; S Takahashi; M Carskadon; W Dement
Journal:  Acta Neurol Scand       Date:  1976-07       Impact factor: 3.209

4.  [Sleep privation with eye movements using antidepressive agents].

Authors:  P Passouant; J Cadilhac; M Ribstein
Journal:  Rev Neurol (Paris)       Date:  1972-07       Impact factor: 2.607

5.  Neurochemical bases of the PGO wave.

Authors:  B L Jacobs; S J Henriksen; W C Dement
Journal:  Brain Res       Date:  1972-12-24       Impact factor: 3.252

6.  Rapid eye movement density and pattern in the sleep of normal young adults.

Authors:  E Aserinsky
Journal:  Psychophysiology       Date:  1971-05       Impact factor: 4.016

7.  Present status of psychological reactions to L-DOPA.

Authors:  W E Bunney
Journal:  Am J Psychiatry       Date:  1970-09       Impact factor: 18.112

8.  Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.

Authors:  L L Butcher; J Engel
Journal:  Brain Res       Date:  1969-09       Impact factor: 3.252

9.  EEG sleep patterns as a function of normal and pathological aging in man.

Authors:  I Feinberg; R L Koresko; N Heller
Journal:  J Psychiatr Res       Date:  1967-06       Impact factor: 4.791

10.  Severe hypermotility during sleep in treatment of cataplexy with clomipramine.

Authors:  E Bental; P Lavie; B Sharf
Journal:  Isr J Med Sci       Date:  1979-07
View more
  2 in total

Review 1.  Drug-induced sleep disturbances. Focus on nonpsychotropic medications.

Authors:  M Novak; C M Shapiro
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

2.  Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.

Authors:  Ariel B Neikrug; Lianqi Liu; Julie A Avanzino; Jeanne E Maglione; Loki Natarajan; Lenette Bradley; Alex Maugeri; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.